Your browser is no longer supported. Please, upgrade your browser.
Settings
NVCN Neovasc Inc. daily Stock Chart
NVCN [NASD]
Neovasc Inc.
Index- P/E- EPS (ttm)-5.64 Insider Own7.84% Shs Outstand7.48M Perf Week-16.45%
Market Cap23.94M Forward P/E- EPS next Y-0.13 Insider Trans0.00% Shs Float6.50M Perf Month-2.74%
Income- PEG- EPS next Q-0.05 Inst Own4.64% Short Float2.36% Perf Quarter12.28%
Sales2.03M P/S11.79 EPS this Y79.70% Inst Trans- Short Ratio2.51 Perf Half Y-36.63%
Book/sh-0.52 P/B- EPS next Y50.00% ROA- Target Price1.88 Perf Year-84.16%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range2.34 - 19.90 Perf YTD-46.93%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-84.02% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low35.90% ATR0.25
Employees98 Current Ratio- Sales Q/Q8.60% Oper. Margin- RSI (14)33.24 Volatility8.10% 6.74%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.21 Prev Close3.20
ShortableYes LT Debt/Eq- EarningsNov 07 AMC Payout- Avg Volume61.16K Price3.18
Recom1.00 SMA20-14.08% SMA50-12.32% SMA200-28.33% Volume48,598 Change-0.62%
Jan-19-18Resumed Canaccord Genuity Buy $1.05
Apr-05-17Upgrade Ladenburg Thalmann Neutral → Buy
May-20-16Downgrade Ladenburg Thalmann Buy → Neutral
Dec-10-15Initiated Ladenburg Thalmann Buy $9.25
Oct-07-15Resumed JMP Securities Mkt Outperform
Apr-02-15Initiated Canaccord Genuity Buy $15
Mar-31-15Initiated Northland Capital Outperform $12
Nov-12-19 07:00AM  Neovasc Reducer(TM) Therapy for Refractory Angina Exceeds 200th Patient Milestone in Germany Newsfile
07:00AM  Neovasc Reducer Therapy for Refractory Angina Exceeds 200th Patient Milestone in Germany GlobeNewswire
Nov-07-19 08:30PM  Neovasc (NVCN) Reports Q3 Loss, Misses Revenue Estimates Zacks
04:05PM  Neovasc Announces Third Quarter 2019 Financial Results GlobeNewswire
07:00AM  Neovasc Appoints Cardiovascular Industry Veteran Bill Little as Chief Operating Officer Newsfile
Nov-06-19 08:30AM  Neovasc to Participate in Stifel 2019 Healthcare Conference and Cannacord Genuity 13th Annual MedTech & Diagnostics Forum GlobeNewswire
Nov-05-19 07:00AM  Neovasc to Provide Update on TF/TS Tiara Program at PCR Valves 2019 Newsfile
07:00AM  Neovasc to Provide Update on TF/TS Tiara Program at PCR Valves 2019 GlobeNewswire
Nov-04-19 09:45AM  What's in Store for DENTSPLY SIRONA (XRAY) in Q3 Earnings? Zacks
08:55AM  What's in the Cards for Cardinal Health (CAH) in Q1 Earnings? Zacks
Nov-01-19 10:26AM  AmerisourceBergen (ABC) to Post Q4 Earnings: What's in Store? Zacks
10:23AM  DexCom (DXCM) to Report Q3 Earnings: What's in the Offing? Zacks
08:30AM  Neovasc to Submit Full PMA Application for Neovasc Reducer in 2019 GlobeNewswire
08:30AM  Neovasc to Submit Full PMA Application for Neovasc Reducer(TM) in 2019 Newsfile
Oct-31-19 10:34AM  Neovasc (NVCN) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Oct-30-19 10:27AM  Neovasc to Participate in the 28th Annual Credit Suisse Healthcare Conference on Wednesday, November 13, 2019 GlobeNewswire
Oct-25-19 07:00AM  Neovasc to Announce Third Quarter 2019 Financial Results on Thursday, November 7, 2019 GlobeNewswire
Oct-22-19 07:00AM  Neovasc Reducer for Treatment of Refractory Angina Featured in Sponsored Session at the 40th Annual National Congress of the Italian Society of Interventional Cardiology GlobeNewswire
07:00AM  Neovasc Reducer(TM) for Treatment of Refractory Angina Featured in Sponsored Session at the 40th Annual National Congress of the Italian Society of Interventional Cardiology Newsfile
Oct-16-19 07:00AM  Neovasc Retains Westwicke, ICR for Integrated Communications Counsel Newsfile
07:00AM  Neovasc Retains Westwicke, ICR for Integrated Communications Counsel GlobeNewswire
Oct-15-19 08:00AM  MicroCap Rodeo Investor Conference; Lineup for October 15 and 16, 2019 ACCESSWIRE +7.03%
07:00AM  Neovasc Announces Notice of US Patent Granted for Tiara(TM) Transcatheter Device for Treatment of Severe Mitral Regurgitation Newsfile
07:00AM  Neovasc Announces Notice of US Patent Granted for Tiara Transcatheter Device for Treatment of Severe Mitral Regurgitation GlobeNewswire
Oct-09-19 07:00AM  Neovasc and GADA® Sponsor Session at the 40th Annual (GISE) National Congress of the Italian Society of Interventional Cardiology Business Wire
Sep-30-19 08:55AM  Neovasc's Tiara for Treatment of Mitral Regurgitation and Neovasc Reducer for Treatment of Refractory Angina Featured in Multiple Presentations at TCT 2019 Conference CNW Group
Sep-23-19 08:55AM  Tiara for Treatment of Mitral Regurgitation and Neovasc Reducer for Treatment of Refractory Angina to be Featured at TCT 2019 Conference CNW Group
Sep-16-19 08:55AM  Neovasc Announces Changes to its Board of Directors PR Newswire
Sep-04-19 08:55AM  Neovasc to Present at the H.C. Wainwright 21st Annual Global Investment Conference CNW Group
Sep-03-19 08:55AM  The European Society of Cardiology Includes Neovasc Reducer for the Treatment of Refractory Angina in the European Practice Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes CNW Group
Aug-22-19 08:55AM  Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency CNW Group
Aug-13-19 09:08AM  Nevro (NVRO) Catches Eye: Stock Jumps 6.3% Zacks -5.32%
Aug-07-19 04:01PM  Neovasc Announces Second Quarter 2019 Financial Results PR Newswire
04:01PM  Neovasc Announces Second Quarter 2019 Financial Results CNW Group
Aug-05-19 08:55AM  Neovasc to Attend Canaccord Genuity 39th Annual Growth Conference PR Newswire +5.78%
Aug-02-19 08:55AM  Neovasc to Announce Second Quarter 2019 Financial Results on Wednesday, August 7th PR Newswire +7.36%
Jul-17-19 03:04PM  Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule, Resolving Last Remaining Outstanding Nasdaq Deficiency PR Newswire
Jul-16-19 08:55AM  Neovasc Provides Further Update on Reducer Program for Treatment of Refractory Angina PR Newswire
Jul-15-19 04:11PM  Neovasc Participates in Round-Robin Study Evaluating In-Vitro Pulsatile Flow Testing of Prosthetic Heart Valves CNW Group
Jul-12-19 08:55AM  Neovasc to Explore HDE Approval Pathway and Alternate Trial Designs for the Reducer Following Guidance from the FDA PR Newswire
08:55AM  Neovasc to Explore HDE Approval Pathway and Alternate Trial Designs for the Reducer Following Guidance from the FDA CNW Group
Jun-28-19 07:00AM  Neovasc Announces Effective Date of Share Consolidation CNW Group -12.47%
Jun-27-19 08:55AM  Neovasc Announces Presentations on Tiara for Treatment of Mitral Regurgitation and Reducer for Treatment of Refractory Angina at the CSI Frankfurt 2019 Conference PR Newswire -10.07%
Jun-25-19 02:30PM  Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule CNW Group +8.33%
Jun-17-19 08:55AM  Tiara Featured in Presentation at 11th Annual TVT 2019 CNW Group +5.03%
Jun-11-19 03:30PM  Penny Stock Neovasc Rallies On Patent Abstract Filing Benzinga +8.47%
Jun-07-19 01:30PM  Neovasc Announces Nasdaq Continuing to Monitor Minimum Market Value Deficiency Following 10 Consecutive Business Days Above US$35 Million PR Newswire
Jun-04-19 02:15PM  Neovasc Inc. Reports Results of Annual General and Special Meeting of Shareholders and Provides Update on Neovasc Reducer PR Newswire
May-28-19 08:55AM  Neovasc Announces Publication of Peer-Reviewed Article in European Heart Journal Concluding Positive Cost-Effectiveness of the Neovasc Reducer PR Newswire
08:55AM  Neovasc Announces Publication of Peer-Reviewed Article in European Heart Journal Concluding Positive Cost-Effectiveness of the Neovasc Reducer CNW Group
May-24-19 12:50PM  A Look At Benzinga Pro's Most-Searched Tickers For May 24 Benzinga
May-23-19 09:17AM  New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in Paris PR Newswire +12.43%
09:17AM  New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in Paris CNW Group
07:37AM  The Daily Biotech Pulse: Breakthrough Therapy Designation For Iovance, Guardant Prices Offering, 2 Stocks to Debut Benzinga
May-22-19 05:30PM  Neovasc Announces Positive Two-Year Follow-up Safety and Efficacy Data for the Neovasc Reducer in a Peer Reviewed Article in the International Journal of Cardiology PR Newswire
May-16-19 08:00PM  Neovasc Announces Closing of Private Placement of Convertible Debt and Common Shares for Gross Proceeds of US$11.5 Million PR Newswire
May-14-19 07:00AM  Neovasc Announces Private Placement of Convertible Debt and Equity for Gross Proceeds of US$11.5 Million PR Newswire +6.32%
May-09-19 05:18PM  Neovasc: 1Q Earnings Snapshot Associated Press +10.87%
04:00PM  /C O R R E C T I O N from Source -- Neovasc Inc./ CNW Group
May-06-19 08:55AM  Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer PR Newswire +6.46%
08:55AM  Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer CNW Group
May-03-19 07:30AM  Neovasc to Announce First Quarter 2019 Financial Results on Thursday, May 9th PR Newswire
07:30AM  Neovasc to Announce First Quarter 2019 Financial Results on Thursday, May 9th CNW Group
Apr-26-19 07:30AM  Neovasc Provides Highlights from Annual Conference of the DGK, the German Society of Cardiology; Symposium Generates Growing Support for Reducer PR Newswire
07:30AM  Neovasc Provides Highlights from Annual Conference of the DGK, the German Society of Cardiology; Symposium Generates Growing Support for Reducer CNW Group
Apr-17-19 03:42PM  Neovasc Announces Resolution of Last Remaining Active Litigation CNW Group +31.16%
07:50AM  Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer Improves Diastolic Function in patients suffering from severe angina PR Newswire
Mar-21-19 05:08PM  Neovasc: 4Q Earnings Snapshot Associated Press
04:01PM  Neovasc Announces Fourth Quarter and Fiscal Year 2018 Financial Results PR Newswire
04:01PM  Neovasc Announces Fourth Quarter and Fiscal Year 2018 Financial Results CNW Group
07:50AM  Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship of a European Patent for Tiara PR Newswire
Mar-19-19 07:50AM  Reducer Featured in Presentation at American College of Cardiology's Annual Meeting PR Newswire
07:50AM  Reducer Featured in Presentation at American College of Cardiology's Annual Meeting CNW Group
Mar-15-19 02:30PM  Neovasc Announces Closing of $5 Million Public Offering of Common Shares PR Newswire
02:30PM  Neovasc Announces Closing of $5 Million Public Offering of Common Shares CNW Group
Mar-14-19 04:01PM  Neovasc Completes Successful Quality System Surveillance Audit PR Newswire
Mar-13-19 04:30PM  Neovasc to Announce Year Ended December 31, 2018 Financial Results on Thursday, March 21 PR Newswire -9.75%
04:30PM  Neovasc to Announce Year Ended December 31, 2018 Financial Results on Thursday, March 21 CNW Group
07:27AM  The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie Benzinga
06:20AM  Neovasc Announces Pricing of $5 Million Public Offering of Common Shares PR Newswire
06:20AM  Neovasc Announces Pricing of $5 Million Public Offering of Common Shares CNW Group
Mar-12-19 04:01PM  Neovasc Announces Proposed Public Offering of Common Shares CNW Group
09:15AM  Neovasc Announces Agreements to Exchange Outstanding Warrants for Shares PR Newswire
09:15AM  Neovasc Announces Agreements to Exchange Outstanding Warrants for Shares CNW Group
Mar-05-19 03:45PM  Neovasc Announces Reducer Implant "Live Case" at the CRT Meeting in Washington, DC PR Newswire +14.71%
03:45PM  Neovasc Announces Reducer Implant "Live Case" at the CRT Meeting in Washington, DC CNW Group
Mar-04-19 01:00PM  Neovasc's Tiara Mitral Valve Replacement Technology Featured in Update Presentation at the CRT 2019 Meeting CNW Group
Feb-28-19 02:55PM  Neovasc announces closing of $5 million public offering of common shares CNW Group +17.50%
Feb-27-19 04:30PM  Neovasc to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference CNW Group
Feb-26-19 06:00AM  Neovasc Announces Pricing of $5 Million Public Offering of Common Shares PR Newswire -28.59%
06:00AM  Neovasc Announces Pricing of $5 Million Public Offering of Common Shares CNW Group
Feb-25-19 04:01PM  Neovasc Announces Proposed Public Offering of Common Shares CNW Group
Feb-22-19 05:30PM  Neovasc Announces Refiling of Interim Financial Statements and Management's Discussion and Analysis for the Period Ended September 30, 2018 CNW Group
Feb-21-19 07:30AM  Neovasc Celebrates 5-Year Anniversary of Tiara Patient as the Longest Surviving Transcatheter Mitral Valve Replacement in the World PR Newswire
Feb-20-19 07:30AM  Neovasc Provides Corporate Update CNW Group
Feb-11-19 07:30AM  Pierangeli Clinic Initiates Program Providing Neovasc Reducer Procedure to Italian Patients with Refractory Angina CNW Group
Jan-30-19 07:30AM  Neovasc Announces Renewal of German NUB Status 1 Designation for Neovasc Reducer Procedure for Treatment of Refractory Angina CNW Group
Jan-29-19 02:30PM  These 4 Healthcare Stocks Healthy With Potential Opportunities ACCESSWIRE +13.54%
07:30AM  Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK PR Newswire
07:30AM  Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK CNW Group
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.